Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-03 Sale | 2021-05-05 4:31 pm | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $26.64 | $66,602 | 166,809 (Direct) | View |
| 2021-04-05 Sale | 2021-04-07 5:17 pm | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $25.54 | $63,848 | 169,309 (Direct) | View |
| 2021-03-03 Sale | 2021-03-04 5:52 pm | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $26.1 | $65,262 | 171,809 (Direct) | View |
| 2021-02-03 Sale | 2021-02-04 5:47 pm | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $25.35 | $63,375 | 174,309 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-03 Exercise | 2021-05-05 4:31 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $0 | 166,809 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 4:31 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $10.86 | 166,809 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-07 5:17 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $0 | 169,309 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-07 5:17 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $10.86 | 169,309 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 5:52 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $0 | 171,809 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 5:52 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $10.86 | 171,809 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 7:01 pm | N/A 2031-02-16 | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-04 5:47 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $0 | 174,309 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-04 5:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer | 2,500 | $10.86 | 174,309 (Direct) | View |